[HTML][HTML] Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives
S Liu, X Chen, T Lin - Journal of advanced research, 2022 - Elsevier
Background Chemotherapy is a first-line treatment for advanced and metastatic bladder
cancer, but the unsatisfactory objective response rate to this treatment yields poor 5-year …
cancer, but the unsatisfactory objective response rate to this treatment yields poor 5-year …
[HTML][HTML] Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives
S Liu, X Chen, T Lin - Journal of Advanced Research, 2022 - ncbi.nlm.nih.gov
Background Chemotherapy is a first-line treatment for advanced and metastatic bladder
cancer, but the unsatisfactory objective response rate to this treatment yields poor 5-year …
cancer, but the unsatisfactory objective response rate to this treatment yields poor 5-year …
Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives
S Liu, X Chen, T Lin - Journal of advanced research, 2022 - pubmed.ncbi.nlm.nih.gov
Background Chemotherapy is a first-line treatment for advanced and metastatic bladder
cancer, but the unsatisfactory objective response rate to this treatment yields poor 5-year …
cancer, but the unsatisfactory objective response rate to this treatment yields poor 5-year …
Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives.
S Liu, X Chen, T Lin - Journal of Advanced Research, 2021 - europepmc.org
Background Chemotherapy is a first-line treatment for advanced and metastatic bladder
cancer, but the unsatisfactory objective response rate to this treatment yields poor 5-year …
cancer, but the unsatisfactory objective response rate to this treatment yields poor 5-year …